Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records

Abstract Background The efficacy of gliclazide has been reported in clinical trials in India. However, real-world data on the effectiveness of gliclazide in India is unavailable. Objective To provide real-world evidence regarding the effectiveness of gliclazide or gliclazide + metformin fixed-dose c...

Full description

Bibliographic Details
Main Authors:	Nareen Krishna Polavarapu, Ravindra Kale, Bipin Sethi, R. K. Sahay, Uday Phadke, Santosh Ramakrishnan, Amey Mane, Suyog Mehta, Snehal Shah
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2020-07-01
Series:	Drugs - Real World Outcomes
Online Access:	https://doi.org/10.1007/s40801-020-00206-7

Similar Items

Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.
by: Belcher, G, et al.
Published: (2005)

Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
by: Sujan Banik, et al.
Published: (2018-01-01)

Fabrication and Characterization of Gliclazide Loaded Microcapsules
by: Muhammad Asad, et al.
Published: (2014-12-01)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
by: Sunitha Sampathi, et al.
Published: (2022-09-01)

Studies on the in vitro phototoxicity of the antidiabetes drug gliclazide.
by: Verónica López, et al.
Published: (2006-12-01)

Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method
by: Rasmita Patra, et al.
Published: (2021-08-01)

Design And Evaluation Of Prolonged Release Gliclazide Matrix Tablets.
by: Abdelraziq Abdelkareem Adam, Fathelrahman
Published: (2007)

Polydimethylsiloxane Organic–Inorganic Composite Drug Reservoir with Gliclazide
by: Ahmed Gedawy, et al.
Published: (2024-04-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
by: Mohamed Nasr, et al.
Published: (2021-08-01)

Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
by: Vatsavai LK, et al.
Published: (2016-11-01)

Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
by: Ali I Al-Gareeb, et al.
Published: (2016-01-01)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01)

Development And Evaluation Of A Matrix Controlled-release Formulation Of Gliclazide
by: Adebaibi, Mahmoud
Published: (2008)

The physiological action of gliclazide: beta-cell function and insulin resistance.
by: Matthews, DR, et al.
Published: (1991)

Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
by: Nina A. Petunina, et al.
Published: (2020-12-01)

Removals of atenolol, gliclazide and prazosin using sequencing batch reactor
by: Mat Zaini, Yasmin Munirah, et al.
Published: (2022)

Removals of atenolol, gliclazide and prazosin using sequencing batch reactor
by: Mat Zaini, Yasmin Munirah, et al.
Published: (2022)

Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
by: Leela Krishna Vatsavai, et al.
Published: (2018-07-01)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
by: Yang Cheng, et al.
Published: (2021-06-01)

Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients
by: Mansour Alsharidah, et al.
Published: (2018-01-01)

Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
by: Matthews, DR, et al.
Published: (2005)

Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.
by: Gribble, F, et al.
Published: (1999)

Gliclazide: Biopharmaceutics Characteristics to Discuss the Biowaiver of Immediate and Extended Release Tablets
by: Bruna de Carvalho Mapa, et al.
Published: (2020-10-01)

Characterization of gliclazide-polyethylene glycol solid dispersion and its effect on dissolution
by: Moreshwar Pandharinath Patil, et al.
Published: (2011-03-01)

Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
by: Subhash Wangnoo, et al.
Published: (2021-09-01)

Advanced and multifaceted stability profiling of the first-line antidiabetic drugs metformin, gliclazide and glipizide under various controlled stress conditions
by: Ahmed Gedawy, et al.
Published: (2020-03-01)

Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
by: I. V. Kononenko, et al.
Published: (2021-11-01)

Biotransformation of caffeine, gliclazide and prazosin in an up-flow anaerobic sludge blanket reactor
by: Azizan, Nur Alyaa Zahida
Published: (2022)

Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
by: Zahra Karami, et al.
Published: (2023-08-01)

Interaction between Omeprazole and Gliclazide in Relation to CYP2C19 Phenotype
by: Tanja Dujic, et al.
Published: (2021-05-01)

Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
by: Khosro Adibkia, et al.
Published: (2019-06-01)

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.
by: Charbonnel, B, et al.
Published: (2005)

Detection of gliclazide in aqueous samples using liquid chromatography/time-of-flight/mass spectrometry
by: Al-Qaim, Fouad Fadhil, et al.
Published: (2016)

Gliclazide MR in the structure of antihyperglycemic therapy according to the data of Moscow region diabetes register
by: I. V. Misnikova, et al.
Published: (2022-05-01)

In Vitro Investigation of Binding Interactions between Albumin–Gliclazide Model and Typical Hypotensive Drugs
by: Ewa Zurawska-Plaksej, et al.
Published: (2021-12-01)

Comparison between S-Allyl Cysteine and Gliclazide in Lowering the Blood Glucose Levels in Diabetic Rats
by: Mashkoor Ahmed Ansari, et al.
Published: (2017-06-01)

Impact of Critical Material Attributes of HPMC on the Release of Gliclazide from Hydrophilic Matrix Tablets
by: Carsten Huettermann, et al.
Published: (2022-11-01)

Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form
by: Hetal Patel, et al.
Published: (2020-05-01)

Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model
by: Aurigena Antunes de ARAÚJO, et al.
Published: (2019-02-01)